Berinert 500 500 Unit (C1 Esterase Inhibitor (Human) KIT) 500 UNIT

BERINERT 500 is a kit containing C1 esterase inhibitor (human) for intravenous use. It is primarily used to manage hereditary angioedema (HAE) attacks. This medication is designed to help control swelling and inflammation associated with HAE.

Strength

500 UNIT

Pack Size

10ML

Manufacturer / TM Owner

CSL BEHRING CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BERINERT 500 is used to treat acute attacks of hereditary angioedema (HAE). HAE is a rare genetic disorder that causes sudden, severe swelling in various parts of the body. The active ingredient, C1 esterase inhibitor (human), works to reduce the symptoms of HAE by inhibiting the enzyme responsible for the swelling. This medication is specifically formulated to provide rapid relief during HAE attacks.

Side Effects

Common effects of BERINERT 500 may include localized reactions at the injection site, such as redness, pain, or swelling. Some individuals might experience headache, nausea, or fatigue. These effects are generally mild and temporary. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

BERINERT 500 should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly to maintain its effectiveness. Individuals with known allergies to any of the components should avoid using this medication. Always inform your healthcare provider about any pre-existing conditions or medications you are taking.

Avoid Interactions

BERINERT 500 may interact with other medications, including those that affect the immune system or blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication. Always follow the advice of a healthcare professional regarding the use of BERINERT 500.

Frequently Asked Questions

BERINERT 500 is used to treat acute attacks of hereditary angioedema (HAE), a condition that causes sudden, severe swelling.

BERINERT 500 is administered intravenously. Follow the instructions provided by a healthcare professional for proper administration.

Common side effects may include localized reactions at the injection site, headache, nausea, or fatigue.

BERINERT 500 may interact with other medications. Consult a healthcare provider before combining it with other treatments.

Store BERINERT 500 as instructed by the manufacturer, typically in a refrigerator, to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.